RHD and congenital adrenal hyperplasia: Early clinical applications of fetal cfDNA for prenatal testing included fetal RhD genotyping [25] and sex determination to aid in the risk assessment of X-linked disorders and congenital adrenal hyperplasia (CAH) utilizing the detection of Y-chromosomes in the plasma of women pregnant with male fetuses [26].